Arete Wealth Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,500	Closed	-$307K	–	323
2025 Q4	$307K	Sell	11,500 -2,125	-16%	-$50.8K	0.02%	590
2025 Q3	$291K	Hold	13,625	–	–	0.02%	617
2025 Q2	$294K	Hold	13,625	–	–	0.02%	566
2025 Q1	$226K	Sell	13,625 -75	-0.5%	-$1.36K	0.02%	631
2024 Q4	$251K	Buy	13,700 +1,875	+16%	+$30.3K	0.02%	615
2024 Q3	$182K	Sell	11,825 -3,875	-25%	-$64.6K	0.02%	661
2024 Q2	$255K	Sell	15,700 -300	-2%	-$4.84K	0.02%	573
2024 Q1	$296K	Buy	+16,000	New	+$396K	0.03%	346
2023 Q4	–	Sell	-16,600	Closed	-$346K	–	743
2023 Q3	$346K	Buy	16,600 +3,950	+31%	+$107K	0.06%	316
2023 Q2	$303K	Sell	12,650 -4,250	-25%	-$94.5K	0.03%	495
2023 Q1	$318K	Sell	16,900 -378	-2%	-$7.2K	0.03%	456
2022 Q4	$275M	Buy	+17,278	New	+$270K	0.02%	478